José-Manuel Gándara-Rey
University of Santiago de Compostela
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by José-Manuel Gándara-Rey.
British Journal of Oral & Maxillofacial Surgery | 2003
Abel García-García; Manuel Somoza-Martín; Pilar Gándara-Vila; Nikola Saulacic; José-Manuel Gándara-Rey
We investigated the efficacy of alveolar distraction for reducing crown height:implant length ratio in the posterior mandible. Ten alveolar distractions were done in seven patients. The pre-distraction ratio of required crown height to bone height available for implantation was in all cases > or =1. Two implants were placed in each distracted area (total 20 implants). Before distraction, the mean (SD) predicted crown height was 12.8 (2.1) mm; mean bone height available for implantation was 7.8 (1.5) mm. After distraction and insertion of implants, mean crown height was 8.1 (1.9) mm, and mean implant length was 11.3 (1.9) mm. Before distraction, the mean required crown height:available bone height ratio was 1.7 (0.3); after distraction and insertion of implants, the mean crown:implant ratio was 0.7 (0.2) (P<0.0005). Alveolar distraction is effective for increasing the height of the alveolar ridge in the posterior mandibular region, and should be considered when the height of the predicted crown that is required is greater than or equal to the maximum height of bone available for implantation.
Medicina Oral Patologia Oral Y Cirugia Bucal | 2013
Mario Pérez-Sayáns; José-Manuel Suárez-Peñaranda; Pilar Gayoso-Diz; Francisco Barros-Angueira; José-Manuel Gándara-Rey; Abel García-García
Oral Squamous Cell Carcinoma (OSCC) is biologically characterized by the accumulation of multiple genetic and molecular alterations that end up clinically characterized as a malignant neoplasm through a phenomenon known as multistep. The members of the Cip/Kip family, specifically p21Waf1/CIP1, are responsible for cell cycle control, blocking the transition from phase G1 to phase S. We made a search of articles of peer-reviewed Journals in PubMed/ Medline, crossing the keywords. The goal of this paper is to determine the relationship between p21Waf1/CIP1 expression and several clinical and pathological aspects of OSCC, their relationship with p53 and HPV, as well as genetic alterations in their expression pattern, their use as a prognosis market in the evolution of precancerous lesions and their roles in anticancer treatments. The results of p21WAF1/CIP1 expression in OSCC showed mixed results in terms of positivity/negativity throughout different studies. It seems that, although p21Waf1/CIP1 expression is controlled in a p53-dependent manner, coexpression of both in OSCC is not intrinsically related. Although the presence of HPV viral oncoproteins increases p21Waf1/CIP1 levels, the small number of studies, have forced us to disregard the hypothesis that HPV infected lesions that present better prognosis are due to a p21Waf1/CIP1–dependent control. The role of p21WAF1/CIP1 as cell-cycle regulator has been well described; however, its relationship to OSCC, the clinical and pathological variables of tumors, HPV and different treatments are not entirely clear. Thus, it would be very interesting to pursue further study of this protein, which may have a significant value for the diagnosis, prognosis and therapy of this type of tumors. Key words:p21Waf1/CIP1, Cip/Kip type cell-cycle regulator, Oral squamous cell carcinoma (OSCC), p53, genetic alterations.
Medicina Oral Patologia Oral Y Cirugia Bucal | 2015
Carmen Vidal-Real; Mario Pérez-Sayáns; José-Manuel Suárez-Peñaranda; José-Manuel Gándara-Rey; Abel García-García
Background Osteonecrosis of the jaw (ONJ) is a destructive bone process in patients undergoing bisphosphonate therapy and it is modulated by local and systemic factors. The purpose of this article is to determine the prevalence of ONJ in patients who have undergone intravenous bisphosphonate therapy, and relate the risk factors described to establish a protocol to reduce the risk of developing ONJ. Material and Methods We performed a retrospective study on 194 patients treated with IV bisphosponates, analyzing clinical and pathological variables. Results The prevalence of ONJ was 12.9 %. The most remarkable complication was pain, which was reported by 80% of patients. The average age of the patients undergoing bisphosphonate therapy was 68.91 years. Most of non-diabetic patients did not develop ONJ (92.3%) (p=0.048). During bisphosphonate therapy, 3.1% of patients underwent extractions in the same percentage in the maxilla and in the mandible; all of which, except for one patient, developed ONJ (p<0.001). In regards to the periodontal state, 94.3% of patients without periodontal problems did not develop ONJ (p=0.001). Almost 50% of the necrosis were located unifocally on the mandible (p<0.001). The number of affected patients and the aggressiveness of the disease increased significantly three years after starting treatment (p<0.001). Conclusions Etiology still is a controversial issue and we should focus on known risk factors, such as the development of surgical procedures in patients undergoing bisphosphonate therapy, especially in patients who have already started their treatment, a group in which ONJ prevalence increases. Moreover, a bad periodontal state in these patients is also an important risk factor, and the control of diabetes reduces it. Due to the above, all patients should be diagnosed and educated in oral hygiene prior to treatment, performing periodical maintenance, to detect possible traumatisms and periodontal infection as soon as possible. Key words:Osteonecrosis of the jaws, intravenous bisphosphonate therapy.
Medicina Oral Patologia Oral Y Cirugia Bucal | 2012
Flavio Seijas-Naya; Tamara García-Carnicero; Pilar Gándara-Vila; Elena Couso-Folgueiras; Mario Pérez-Sayáns; Rafael Gándara-Vila; Abel García-García; José-Manuel Gándara-Rey
Objective: We aim to evaluate the effectiveness of the brush biopsy technique using OralCDx ® (OralScan Laboratories Inc., Suffern, NY) as a new method for early diagnosis and control of a “potentially malignant disorder” such as oral leukoplakia. Design of the study: We performed a study in which samples were taken using OralCDx ® on 24 patients who visited the Master of Oral Medicine, Oral Surgery and Implantology of the University of Santiago de Compostela between February 2009 and May 2010. These patients presented clinical and histological lesions that were consistent with oral leukoplakia. We evaluated the relationship between the keratinization degree of the lesions and cell representation; the diagnosis obtained through OralCDx ® and biopsies; and sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV). Results: 50% of patients were men and 50% women with an average age of 62.38 years. The Kappa coefficient relating keratinization of lesions and cell representation was 0.33, the OralCDx ® - biopsy diagnostic rate reached a Kappa value of 0.66, recording 72.7%,sensitivity and 92.3% specificity, PPV was 88.8%, while NPV reached 80%. Conclusions: cytology sampling with OralCDx ® showed high sensitivity and specificity values, which make it a good tool for monitoring oral leukoplakia, but nowadays the most reliable method that allows us to confirm the exact diagnosis of the lesions and their anatomical and pathological characteristics still is conventional biopsy using a surgical scalpel. Key words: OralCDx®, brush biopsy, oral leukoplakia.
Journal of Oral and Maxillofacial Surgery | 2006
Lucía Lago-Méndez; Márcio Diniz-Freitas; Carmen Senra-Rivera; Gloria Seoane-Pesqueira; José-Manuel Gándara-Rey; Abel García-García
Oral Diseases | 2006
A González-García; Márcio Diniz-Freitas; Pilar Gándara-Vila; Andrés Blanco-Carrión; Abel García-García; José-Manuel Gándara-Rey
Medicina Oral Patologia Oral Y Cirugia Bucal | 2011
Francisca Fernández-González; Rocío Vázquez-Álvarez; Dolores Reboiras-López; Pilar Gándara-Vila; Abel García-García; José-Manuel Gándara-Rey
Oral Diseases | 2007
Márcio Diniz-Freitas; T García-Caballero; J Antúnez-López; José-Manuel Gándara-Rey; Abel García-García
Medicina Oral Patologia Oral Y Cirugia Bucal | 2010
Rocío Vázquez-Álvarez; Francisca Fernández-González; Pilar Gándara-Vila; Dolores Reboiras-López; Abel García-García; José-Manuel Gándara-Rey
Medicina Oral Patologia Oral Y Cirugia Bucal | 2005
Lago-Méndez L; Blanco-Carrión A; Márcio Diniz-Freitas; Pilar Gándara-Vila; Abel García-García; José-Manuel Gándara-Rey